A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report

BACKGROUND: Bupropion is approved for the treatment of mood disorders and as an adjuvant medication for smoking cessation. Bupropion is generally well tolerated and considered safe. Two randomized controlled trials of bupropion therapy for smoking cessation did not report any hepatic adverse events....

Descripción completa

Detalles Bibliográficos
Autores principales: Humayun, Fawwaz, Shehab, Thomas M, Tworek, Joseph A, Fontana, Robert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008202/
https://www.ncbi.nlm.nih.gov/pubmed/17877816
http://dx.doi.org/10.1186/1752-1947-1-88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008202/
https://www.ncbi.nlm.nih.gov/pubmed/17877816
http://dx.doi.org/10.1186/1752-1947-1-88

Ejemplares similares